COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN AUSTRIA

被引：4
|
作者：
Walter, E. [1 ]
Bauer, M. [1 ]
Ressl, S. [1 ]
机构：
[1] Inst Pharmaecon Res, Vienna, Austria
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.876
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV107
引用
收藏
页码：A392 / A392
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
    Mikio Momoeda
    Kyoko Ito
    Sachie Inoue
    Hidetoshi Shibahara
    Yuko Mitobe
    Norio Komatsu
    International Journal of Hematology, 2025, 121 (4) : 467 - 475
  • [32] Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia
    Basha, Ahmed
    Izham, Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdulla, Mohammad Abdul-Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmed A.
    Shwaylia, Hawraa M.
    Ekeibed, Yeslem Mohamed Aly
    AbuMousa, Rami
    Yassin, Mohamed A.
    BLOOD, 2020, 136
  • [33] Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis
    Rangwala, Burhanuddin Sohail
    Zuhair, Varisha
    Mustafa, Muhammad Saqlain
    Mussarat, Abdullah
    Khan, Aimen Waqar
    Danish, Fnu
    Fatima Zaidi, Syeda Mahrukh
    Rehman, Faizan Ur
    Shafique, Muhammad Ashir
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [34] Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
    Basha, Ahmad
    Ibrahim, Mohamed Izham Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdullah, Mohamed Abdul Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmad A.
    Shwaylia, Hawraa M.
    Ekeibed, Yaslem
    AbuMousa, Rami
    Yassin, Mohamed A.
    PLOS ONE, 2021, 16 (08):
  • [35] Effectiveness and safety in the administration of carboxymaltose iron in outpatients with iron deficiency and heart failure
    Lozano-Edo, S.
    Arenas, P.
    Jover-Pastor, P.
    Ezzitouny, M.
    Sorolla, J.
    Calvo, M.
    Martinez-Sole, J.
    Guerrero, B.
    Sanchez, J. C.
    Navarrete, J.
    Donoso, V.
    Lopez-Vilella, R.
    Sanchez-Lazaro, I.
    Martinez-Dolz, L.
    Almenar, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 120 - 121
  • [36] Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study
    Capone, Federico
    Cipriani, Alberto
    Molinari, Leonardo
    Noale, Marianna
    Gusella, Beatrice
    Lucente, Fabrizio
    Savino, Sandro
    Bertomoro, Antonella
    Saller, Alois
    Giannini, Sandro
    Vettor, Roberto
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (08):
  • [37] Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland
    Brock, Elisabeth
    Moschovitis, Giorgio
    Maeder, Micha T.
    Pfister, Otmar
    PHARMACOECONOMICS-OPEN, 2022, 6 (05) : 735 - 743
  • [38] Ferric Carboxymaltose in Iron Deficient Patients Admitted for Acute Heart Failure
    Ponikowski, Piotr
    Anker, Stefan D.
    Kirwan, Bridget-Anne
    Maria, Dorobantu
    Drozdz, Jaroslaw
    Fabien, Vincent
    Filippatos, Gerasimos
    Friede, Tim
    Goehring, Udo-Michael
    Keren, Andre
    Khintibidze, Irakli
    Kragten, Hans
    Martinez, Felipe A.
    McDonagh, Theresa
    Metra, Marco
    Milicic, Davor
    Nicolau, Jose C.
    Ohlsson, Marcus
    Parhomenko, Alexander
    Figal, Domingo Pascual
    Ruschitzka, Frank
    Sim, David
    Skouri, Hadi
    Van der Meer, Peter D.
    Jankowska, Ewa A.
    CIRCULATION, 2020, 142 (24) : E482 - E482
  • [39] A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
    Pollock, Richard F.
    Muduma, Gorden
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 751 - 759
  • [40] Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland
    Elisabeth Brock
    Giorgio Moschovitis
    Micha T. Maeder
    Otmar Pfister
    PharmacoEconomics - Open, 2022, 6 : 735 - 743
12345